The ROS-1 NSCLC current market is mainly dominated by tyrosine kinase inhibitors such as XALKORI at present and is anticipated to be dominated by Repotrectinib, Taletrectinib, and NVL-520 by 2034.
Total Quarterly Revenue of $4 million, up 9% year-over-year.Record Backlog of $54.9 million.Gross Margin of 42%.Cost-Cutting ...
In recent years, in search of long-term power solutions and concerned about climate change, the European Space Agency has been ... with only about 10 employees at present. "It's beyond my ...
Featured companies in Skypointer fund's current portfolio include industry leaders such as Scale AI, the artificial intelligence company that recently raised a series F led by Accel along with Nvidia ...
JWST, a groundbreaking space observatory, enhances our understanding of the cosmos by studying distant galaxies, star ...
Hubble Space TelescopeHomeNASA's Hubble, Webb… Hubble Space Telescope Hubble HomeOverviewAbout HubbleThe History of HubbleHubble TimelineWhy Have a ...
UN nuclear watchdog chief visits Tehran for talks aimed at more monitoring cooperation at Iran’s nuclear sites.
AROBS Polska and Romania's AROBS Engineering have been selected by the European Space Agency (ESA ... will meet several European integrators to present the preliminary architecture of the device ...
The likely US departure from global climate-crisis efforts offers an opening for Bejing, a clean-tech giant.
Avio USA, a subsidiary of Avio S.p.A ., has selected ACMI Properties to design and plan its first solid rocket motor ...
R&D budget cuts. Visa restrictions. Anti-China policies. Political witch hunts on campus: these are among the scary memes ...
Born and raised in Mexico City, Carlos Fontanot has dedicated 34 years to NASA. He supports the International Space Station ...